Answers are grounded in this paper and cite their sources.
Finerenone is effective and safe in chronic kidney disease (CKD) with type 2 diabetes mellitus (T2DM) in phase III clinical trials. However, no data from clinical trials and real-world is available on the effectiveness of finerenone in CKD patients without diabetes mellitus(DM).
No takes yet. Share an insight, caveat, or question.
XINGZHI WANG (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: